201. Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results.
- Author
-
Frisoni GB, Pizzolato G, Bianchetti A, Chierichetti F, Ferlin G, Battistin L, and Trabucchi M
- Subjects
- Aged, Basal Ganglia diagnostic imaging, Basal Ganglia physiopathology, Cerebellum diagnostic imaging, Cerebellum physiopathology, Cerebral Ventricles diagnostic imaging, Cerebral Ventricles physiopathology, Cerebrospinal Fluid diagnostic imaging, Female, Humans, Male, Middle Aged, Receptors, Dopamine, Alzheimer Disease diagnostic imaging, Alzheimer Disease physiopathology, Dementia diagnostic imaging, Dementia physiopathology, Frontal Lobe physiopathology, Technetium Compounds, Tomography, Emission-Computed, Single-Photon
- Abstract
Dementia of frontal type (DFT) is a fairly common degenerative disease distinct from Alzheimer's disease (AD), whose reportedly distinctive instrumental feature is frontal lobe hypoperfusion on SPECT. We evaluated the cortical dopaminergic system in 6 AD, 5 DFT, and 6 control subjects with SPECT and both [99Tc]-HM-PAO, a perfusion tracer, and [123I]-IBZM, a D2 postsynaptic ligand. Both in AD and DFT patients, [99Tc]-HM-PAO SPECT showed a relative frontal hypoperfusion. On the contrary, [123I]-IBZM SPECT showed significantly reduced ligand uptake in superior frontal regions of DFT (0.89 +/- 0.08 relative to control subjects) as compared to AD patients (0.97 +/- 0.02; difference of means: 0.08, 95% Confidence Interval 0.004 to 0.156; p = 0.041). Results suggest more marked involvement of the frontal cortical dopaminergic system in DFT than in AD patients.
- Published
- 1994
- Full Text
- View/download PDF